centerforbiosimilars1d
FDA Reviews Golimumab Biosimilar, Samsung Biologics Hits Record Sales, Japan Approves Stelara Biosimilar
The FDA accepted applications for a golimumab biosimilar, while Samsung Biologics reported record sales, and a Japanese ...
The Korea Bizwire1d
South Korean Pharmaceutical Companies Make Bold Push Into Autoimmune Disease Market
Celltrion, a leading Korean biotechnology firm, has successfully developed Zymfentra, a subcutaneous version of the company’s ...
The American Journal of Managed Care4d
Psoriasis Treatment Remains Effective, Safe After Switch From Ustekinumab to Biosimilar SB17
Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...
The American Journal of Managed Care4d
Ustekinumab Biosimilar Launches in France, Shifts the Autoimmune Disease Market
An ustekinumab biosimilar to Stelara launched in France, completing its rollout across 5 major European markets and paving ...
J&J beats quarterly sales and profit estimates on cancer drug sales
Johnson amp Johnson exceeded Wall Street expectations for fourth-quarter revenue and profit with robust sales of cancer ...